Advertisement Vitrolife's CFO to resign - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vitrolife’s CFO to resign

Vitrolife, a biotechnology and medical device Group, has announced that Anna Ahlberg, CFO, has decided to resign from her position.

Ms Ahlberg will terminate her employment at Vitrolife in January 2009. The work of recruiting her successor is ongoing.

Ms Ahlberg will begin to work at Global Health Partner, as head of the company’s spine surgery business unit.

Magnus Nilsson, CEO, said: “Anna has done a great job at Vitrolife, amongst other things by organizing and structuring our finance activities so that they are at a recognized very high level. We wish her the very best of luck in her new position.”